Patents by Inventor Gérard Audran

Gérard Audran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Proteasome inhibiting ?-lactam prodrugs useful for the treatment of cancer and neurodegenerative disorders
    Patent number: 11053249
    Abstract: The present invention relates generally to proteasome inhibiting ?-lactam compounds useful for the treatment of cancer and neurodegenerative disorders. The invention also provides pharmaceutical compositions and extended release formulations of said compounds, and medical uses of said compounds and/or pharmaceutical compositions to treat cancer and neurodegenerative disorders.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: July 6, 2021
    Assignees: Philippe Yves-Remy Simon, VITA API
    Inventors: Philippe Yves-Rémy Simon, Henri Oreal, Gérard Audran, Marvin Schulz, Jean-Patrick Joly, Didier Siri, Anouk Siri
  • Proteasome Inhibiting Beta-Lactam Produrgs Useful for the Treatment of Cancer and Nurodegenerative Disorders
    Publication number: 20200216455
    Abstract: The present invention relates generally to proteasome inhibiting ?-lactam compounds useful for the treatment of cancer and neurodegenerative disorders. The invention also provides pharmaceutical compositions and extended release formulations of said compounds, and medical uses of said compounds and/or pharmaceutical compositions to treat cancer and neurodegenerative disorders.
    Type: Application
    Filed: December 22, 2017
    Publication date: July 9, 2020
    Applicants: Vita Api, Etat Français Représenté Par le Directeur Central du Service de Santé des Armées, Université D'Aix-Marseille, Centre National de la Recherche Scientifique
    Inventors: Philippe Yves-Rémy Simon, Henri Oreal, Gérard Audran, Marvin Schulz, Jean-Patrick Joly, Didier Siri, Anouk Siri
  • Alkoxyamines for the treatment of cancers
    Patent number: 10421725
    Abstract: The present invention relates to alkoxyamines of general formula (I), and to compounds of general formula (IIa), (IIb), (IIc), (IId), IIe), (IIf) or (IIg), as such and for the treatment of cancers.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: September 24, 2019
    Assignees: Centre National de la Recherche Scientifique, Universite d'aix Marseille, Universite de Bordeaux
    Inventors: Philippe Mellet, Sylvain Marque, Jean-Michel Franconi, Pierre Voisin, Damien Moncelet, Paul Bremond, Gérard Audran
  • ALKOXYAMINES FOR THE TREATMENT OF CANCERS
    Publication number: 20160115130
    Abstract: The present invention relates to alkoxyamines of general formula (I), and to compounds of general formula (IIa), (IIb), (IIc), (IId), IIe), (IIf) or (IIg), as such and for the treatment of cancers.
    Type: Application
    Filed: June 13, 2014
    Publication date: April 28, 2016
    Applicants: Centre National De La Recherche Scientifique, Universite d'Aix Marseille, Universite de Bordeaux
    Inventors: Philippe Mellet, Sylvain Marque, Jean-Michel Franconi, Pierre Voisin, Damien Moncelet, Paul Bremond, Gérard Audran